Petros Pharmaceuticals Inc. has approved new restricted stock unit (RSU) grants for key members of its leadership and board. Effective January 2, 2026, Chairman Joshua Silverman will receive 4,375,000 RSUs, director Bruce Bernstein will receive 1,875,000 RSUs, President and Chief Commercial Officer Fady Boctor will receive 500,000 RSUs, and director Wayne Walker will receive 500,000 RSUs. Half of each grant vests immediately, with the remaining half vesting six months later, contingent on continued service. These RSUs were issued outside the company's 2020 Omnibus Incentive Compensation Plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Petros Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-000236), on January 02, 2026, and is solely responsible for the information contained therein.